Reduction of venous pressure during the resection of liver metastases compromises enteric blood flow: IGFBP-1 as a novel biomarker of intestinal barrier injury

Detalhes bibliográficos
Autor(a) principal: Barbeiro, Hermes Vieira
Data de Publicação: 2017
Outros Autores: Machado, Marcel Autran César, de Souza, Heraldo Possolo, da Silva, Fabiano Pinheiro, Machado, Marcel Cerqueira César
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/141022
Resumo: OBJECTIVES: Disruption of the intestinal barrier and bacterial translocation commonly occur when intestinal blood flow is compromised. The aim of this study was to determine whether liver resection induces intestinal damage. METHODS: We investigated intestinal fatty-acid binding protein and insulin-like growth factor binding protein levels in the plasma of patients who underwent liver resection. RESULTS: We show that liver resection is associated with significant intestinal barrier injury, even if the Pringle maneuver is not performed. CONCLUSION: We propose the use of insulin-like growth factor binding protein-1 as a novel biomarker of intestinal damage in such situations.
id USP-19_17af99fdbb617d0606ab32b9ac2a0327
oai_identifier_str oai:revistas.usp.br:article/141022
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling Reduction of venous pressure during the resection of liver metastases compromises enteric blood flow: IGFBP-1 as a novel biomarker of intestinal barrier injuryLiverInflammationIntestinal BarrierBacterial TranslocationIGFBP-1OBJECTIVES: Disruption of the intestinal barrier and bacterial translocation commonly occur when intestinal blood flow is compromised. The aim of this study was to determine whether liver resection induces intestinal damage. METHODS: We investigated intestinal fatty-acid binding protein and insulin-like growth factor binding protein levels in the plasma of patients who underwent liver resection. RESULTS: We show that liver resection is associated with significant intestinal barrier injury, even if the Pringle maneuver is not performed. CONCLUSION: We propose the use of insulin-like growth factor binding protein-1 as a novel biomarker of intestinal damage in such situations.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2017-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/14102210.6061/clinics/2017(10)10Clinics; Vol. 72 No. 10 (2017); 645-648Clinics; v. 72 n. 10 (2017); 645-648Clinics; Vol. 72 Núm. 10 (2017); 645-6481980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/141022/136088Copyright (c) 2017 Clinicsinfo:eu-repo/semantics/openAccessBarbeiro, Hermes VieiraMachado, Marcel Autran Césarde Souza, Heraldo Possoloda Silva, Fabiano PinheiroMachado, Marcel Cerqueira César2017-11-27T13:14:34Zoai:revistas.usp.br:article/141022Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2017-11-27T13:14:34Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Reduction of venous pressure during the resection of liver metastases compromises enteric blood flow: IGFBP-1 as a novel biomarker of intestinal barrier injury
title Reduction of venous pressure during the resection of liver metastases compromises enteric blood flow: IGFBP-1 as a novel biomarker of intestinal barrier injury
spellingShingle Reduction of venous pressure during the resection of liver metastases compromises enteric blood flow: IGFBP-1 as a novel biomarker of intestinal barrier injury
Barbeiro, Hermes Vieira
Liver
Inflammation
Intestinal Barrier
Bacterial Translocation
IGFBP-1
title_short Reduction of venous pressure during the resection of liver metastases compromises enteric blood flow: IGFBP-1 as a novel biomarker of intestinal barrier injury
title_full Reduction of venous pressure during the resection of liver metastases compromises enteric blood flow: IGFBP-1 as a novel biomarker of intestinal barrier injury
title_fullStr Reduction of venous pressure during the resection of liver metastases compromises enteric blood flow: IGFBP-1 as a novel biomarker of intestinal barrier injury
title_full_unstemmed Reduction of venous pressure during the resection of liver metastases compromises enteric blood flow: IGFBP-1 as a novel biomarker of intestinal barrier injury
title_sort Reduction of venous pressure during the resection of liver metastases compromises enteric blood flow: IGFBP-1 as a novel biomarker of intestinal barrier injury
author Barbeiro, Hermes Vieira
author_facet Barbeiro, Hermes Vieira
Machado, Marcel Autran César
de Souza, Heraldo Possolo
da Silva, Fabiano Pinheiro
Machado, Marcel Cerqueira César
author_role author
author2 Machado, Marcel Autran César
de Souza, Heraldo Possolo
da Silva, Fabiano Pinheiro
Machado, Marcel Cerqueira César
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Barbeiro, Hermes Vieira
Machado, Marcel Autran César
de Souza, Heraldo Possolo
da Silva, Fabiano Pinheiro
Machado, Marcel Cerqueira César
dc.subject.por.fl_str_mv Liver
Inflammation
Intestinal Barrier
Bacterial Translocation
IGFBP-1
topic Liver
Inflammation
Intestinal Barrier
Bacterial Translocation
IGFBP-1
description OBJECTIVES: Disruption of the intestinal barrier and bacterial translocation commonly occur when intestinal blood flow is compromised. The aim of this study was to determine whether liver resection induces intestinal damage. METHODS: We investigated intestinal fatty-acid binding protein and insulin-like growth factor binding protein levels in the plasma of patients who underwent liver resection. RESULTS: We show that liver resection is associated with significant intestinal barrier injury, even if the Pringle maneuver is not performed. CONCLUSION: We propose the use of insulin-like growth factor binding protein-1 as a novel biomarker of intestinal damage in such situations.
publishDate 2017
dc.date.none.fl_str_mv 2017-10-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/141022
10.6061/clinics/2017(10)10
url https://www.revistas.usp.br/clinics/article/view/141022
identifier_str_mv 10.6061/clinics/2017(10)10
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/141022/136088
dc.rights.driver.fl_str_mv Copyright (c) 2017 Clinics
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2017 Clinics
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 72 No. 10 (2017); 645-648
Clinics; v. 72 n. 10 (2017); 645-648
Clinics; Vol. 72 Núm. 10 (2017); 645-648
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222763270537216